X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
aged (10) 10
female (10) 10
middle aged (10) 10
oncology (10) 10
adult (9) 9
index medicus (8) 8
male (8) 8
animals (7) 7
extracellular-matrix (7) 7
phosphorylation (7) 7
aged, 80 and over (6) 6
cell adhesion (6) 6
biochemistry & molecular biology (5) 5
chemotherapy (5) 5
integrins - metabolism (5) 5
mice (5) 5
protein-tyrosine kinases - metabolism (5) 5
3t3 cells (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
care and treatment (4) 4
cell biology (4) 4
erlotinib (4) 4
erlotinib hydrochloride (4) 4
focal adhesion kinase 1 (4) 4
focal adhesion protein-tyrosine kinases (4) 4
human endothelial-cells (4) 4
lung neoplasms - drug therapy (4) 4
signal transduction (4) 4
signal-transduction (4) 4
tyrosine - metabolism (4) 4
tyrosine phosphorylation (4) 4
advanced nsclc (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
cell adhesion molecules - metabolism (3) 3
cell line (3) 3
fluorescent antibody technique (3) 3
hematology, oncology and palliative medicine (3) 3
integrins - physiology (3) 3
lung cancer, non-small cell (3) 3
lung neoplasms - mortality (3) 3
lung neoplasms - pathology (3) 3
medicine (3) 3
metastasis (3) 3
pp125 (3) 3
pulmonary/respiratory (3) 3
respiratory system (3) 3
survival (3) 3
targeted therapy (3) 3
therapy (3) 3
transfection (3) 3
actins - metabolism (2) 2
actins - physiology (2) 2
activation (2) 2
adolescent (2) 2
analysis (2) 2
anesthesiology (2) 2
apoptosis (2) 2
base sequence (2) 2
breast cancer (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - diagnosis (2) 2
cirrhosis (2) 2
cisplatin (2) 2
cisplatin - administration & dosage (2) 2
cisplatin - adverse effects (2) 2
cricetinae (2) 2
cross-sectional studies (2) 2
cycle progression (2) 2
cytoskeleton - metabolism (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
dna-binding proteins - metabolism (2) 2
docetaxel (2) 2
dose-response relationship, drug (2) 2
endothelium, vascular - metabolism (2) 2
enzyme activation (2) 2
enzyme activation - genetics (2) 2
extracellular matrix proteins - metabolism (2) 2
fibronectin (2) 2
focal adhesion kinase (2) 2
gastroenterology & hepatology (2) 2
gefitinib (2) 2
gene expression (2) 2
gene expression regulation - genetics (2) 2
gene-expression (2) 2
genes, fos (2) 2
genotype (2) 2
hair (2) 2
hepacivirus - classification (2) 2
histology (2) 2
integrins (2) 2
italy (2) 2
janus kinase 2 (2) 2
kaplan-meier estimate (2) 2
lung cancer (2) 2
lung neoplasms - diagnosis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, p. e103883
Introduction: Assessment of EGFR mutation in non-small cell lung cancer (NSCLC) patients is mandatory for optimization of pharmacologic treatment. In this... 
BREAST-CANCER | MOLECULAR CHARACTERIZATION | SURVIVAL | THERAPY | DNA | MULTIDISCIPLINARY SCIENCES | PROGRESSION-FREE | FACTOR-RECEPTOR MUTATIONS | DISCORDANCE | EXPRESSION | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Neoplastic Cells, Circulating - pathology | Exons | Humans | Molecular Sequence Data | Neoplastic Cells, Circulating - metabolism | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Case-Control Studies | Base Sequence | Sensitivity and Specificity | Carcinoma, Non-Small-Cell Lung - pathology | Gene Expression | Biomarkers, Tumor - blood | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Carcinoma, Non-Small-Cell Lung - blood | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung Neoplasms - diagnosis | Care and treatment | Genetic aspects | Lung cancer, Non-small cell | Analysis | Tumors | Lung cancer | Medical services | Oncology | Metastasis | Kinases | Cancer therapies | Nuclei | Blood | Optimization | Aging | Deoxyribonucleic acid--DNA | Sequences | Epidermal growth factor receptors | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Pharmacology | Real time | Patients | Medicine | Chemotherapy | Hospitals | Biopsy | Experimental design | Diagnostic software | Diagnostic systems | Prostate cancer | Cancer | Deoxyribonucleic acid
Journal Article
Frontiers in Cellular Neuroscience, ISSN 1662-5102, 09/2015, Volume 9, Issue september, p. 338
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2016, Volume 27, Issue suppl 2, pp. ii48.1 - ii48
Journal Article
BMC Neuroscience, ISSN 1471-2202, 2013, Volume 14, Issue Suppl 1, p. P313
Journal Article
Cogent Mathematics, ISSN 2331-1835, 12/2016, Volume 3, Issue 1
A nonlinear ecoepidemic model of new type is introduced here, in that it contains genetically distinguishable subpopulations. Further, in the system a predator... 
transmissible diseases | epidemics | predator-prey | Secondary: 92D10 | Primary: 92D25 | 92D40 | genetic variability | Epidemics | Demographics | Predators | predator–prey
Journal Article
Journal Article
Italian Journal of Medicine, ISSN 1877-9344, 12/2018, Volume 12, Issue 4, pp. 276 - 279
Castleman disease (CD) is a rare lymphoproliferative disorder also known as angiofollicular lymph node hyperplasia or giant lymph node hyperplasia. CD can be... 
Castleman disease | Lymphoproliferative disorder | Multicentric castleman disease | multicentric Castleman disease | lymphoproliferative disorder
Journal Article
Journal Article
Italian Journal of Medicine, ISSN 1877-9344, 2014, Volume 8, Issue 1, pp. 44 - 50
Urticarial vasculitis is a small-vessel vasculitis characterized clinically by urticaria and microscopically by leukocytoclastic vasculitis. Hypocomplementemic... 
Leukocytoclastic vasculitis | Hypocomplementemic urticarial vasculitis | Diffuse alveolar hemorrhage | hypocomplementemic urticarial vasculitis, leukocytoclastic vasculitis, diffuse alveolar hemorrhage
Journal Article
by Cortegiani, A and Gregoretti, C and Neto, A.S and Hemmes, S.N.T and Hemmes, S and Ball, L and Canet, J and Hiesmayr, M and Hollmann, M and Hollmann, M.W and Mills, G.H and Mills, G and Melo, M.F.V and Melo, M.V and Putensen, C and Schmid, W and Severgnini, P and Wrigge, H and Gama de Abreu, M and Schultz, M and Schultz, M.J and Pelosi, P and Kroell, W and Metzler, H and Struber, G and Wegscheider, T and Gombotz, H and Urbanek, B and Kahn, D and Momeni, M and Pospiech, A and Lois, F and Forget, P and Grosu, I and Poelaert, J and Mossevelde, V and van Malderen, M.C and Dylst, D and Melkebeek, J.V and Beran, M and Hert, S.D and Baerdemaeker, L.D and Heyse, B and Limmen, J.V and Wyffels, P and Jacobs, T and Roels, N and Bruyne, A.D and Velde, S.V.D and Marina, J.Z and Dejana, D.O and Pernar, S and Zunic, J and Miskovic, P and Zilic, A and Kvolik, S and Ivic, D and Darija, A.V and Skiljic, S and Vinkovic, H and Oputric, I and Juricic, K and Frkovic, V and Kopic, J and Mirkovic, I and Saric, J.P and Erceg, G and Dvorscak, M.B and Branka, M.S and Pavicic, A.M and Goranovic, T and Maldini, B and Radocaj, T and Gavranovic, Z and Inga, M.B and Sehovic, M and Stourac, P and Harazim, H and Smekalova, O and Kosinova, M and Kolacek, T and Hudacek, K and Drab, M and Brujevic, J and Vitkova, K and Jirmanova, K and Volfova, I and Dzurnakova, P and Liskova, K and Dudas, R and Filipsky, R and Kafrawy, S.E and Abdelwahab, H.H and Metwally, T and Ahmed, A.G and Ahmed, A.R and Ahmed Mostafa, E.S and Hasan, W.F and Yassin, H and Magdy, M and ... and PROVE Network and European Soc Anaesthesiology and LAS VEGAS Investigators and LAS VEGAS Investigators, the PROVE Network, and the Clinical Trial Network of the European Society of Anaesthesiology
British Journal of Anaesthesia, ISSN 0007-0912, 03/2019, Volume 122, Issue 3, pp. 361 - 369
The aim of this analysis of a large cohort study was to evaluate the association between night-time surgery and the occurrence of intraoperative adverse events... 
intraoperative complications | postoperative complications | pulmonary | patient safety | general anaesthesia | MORTALITY | PERFORMANCE | SLEEP-DEPRIVATION | MECHANICAL VENTILATION | TIME | STRATEGIES | ANESTHESIA | INCREASED RISK | ANESTHESIOLOGY | OUTCOMES
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2009, Volume 64, Issue 1, pp. 67 - 72
This study evaluated the maximum tolerated dose (MTD) and the dose limiting toxicity (DLT) of erlotinib when combined to irinotecan and capecitabine in... 
Irinotecan | Biomedicine | Erlotinib | Capecitabine | Colorectal cancer | Cancer Research | Oncology | Pharmacology/Toxicology | XENOGRAFT MODELS | LEUCOVORIN | PLUS IRINOTECAN | SOLID TUMORS | OSI-774 | OXALIPLATIN | ANTITUMOR-ACTIVITY | PHASE-II TRIAL | ONCOLOGY | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | INFUSIONAL 5-FLUOROURACIL | Erlotinib Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fever - chemically induced | Dose-Response Relationship, Drug | Neoplasm Metastasis | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Quinazolines - administration & dosage | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Drug Eruptions - etiology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Mucositis - chemically induced | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Deoxycytidine - analogs & derivatives | Cohort Studies | Care and treatment | Oncology, Experimental | Metastasis | Research | Antineoplastic agents | Fever | Antimitotic agents | Cancer patients | Pharmacy | Dosage and administration | Hyperthermia | Cancer | Index Medicus
Journal Article